Altria Group, Inc. reported a decrease in net revenues and reported diluted EPS for Q2 2022 compared to Q2 2021. However, adjusted diluted EPS increased. The company reaffirms its guidance for 2022 full-year adjusted diluted EPS.
Smokeable products segment delivered solid operating companies income growth, driven by Marlboro's resilience.
Progress made toward Vision through investments, including supporting the expansion of on!.
FDA has the opportunity to create a mature, regulated marketplace of smoke-free products.
Reaffirmed guidance to deliver 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93.
Altria reaffirms its guidance to deliver 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93, representing a growth rate of 4% to 7% from an adjusted diluted EPS base of $4.61 in 2021.
Visualization of income flow from segment revenue to net income